106 related articles for article (PubMed ID: 1394124)
1. Quantitative imaging of a radiotherapeutic drug, Na2B12H11SH, at subcellular resolution in tissue cultures using ion microscopy.
Zha X; Ausserer WA; Morrison GH
Cancer Res; 1992 Oct; 52(19):5219-22. PubMed ID: 1394124
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of boron-10 (10B) in cell cultures exposed to mercaptododecaborate (Na2H(11)10B12SH) used for the neutron capture therapy of brain tumors.
Mares V; Baudysová M; Kvítek J; Hnatovicz V; Cervená J; Vacík J; Folbergrová J
J Pharmacol Exp Ther; 1992 Aug; 262(2):818-22. PubMed ID: 1501124
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
[TBL] [Abstract][Full Text] [Related]
4. Subcellular boron-10 localization in glioblastoma for boron neutron capture therapy with Na2B12H11SH.
Haselsberger K; Radner H; Gössler W; Schlagenhaufen C; Pendl G
J Neurosurg; 1994 Nov; 81(5):741-4. PubMed ID: 7931621
[TBL] [Abstract][Full Text] [Related]
5. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
6. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Tjarks W; Lorey DR; Barth RF
J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
[TBL] [Abstract][Full Text] [Related]
7. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Pettersson OA; Carlsson J; Grusell E
Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968
[TBL] [Abstract][Full Text] [Related]
9. Dynamic SIMS ion microscopy imaging of intracellular boron accumulation from carboranyl nucleosides in glioma cells.
Gay I; Lorey DR; Schinazi RF; Morrison GH; Chandra S
Anticancer Res; 2001; 21(4A):2369-75. PubMed ID: 11724295
[TBL] [Abstract][Full Text] [Related]
10. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations.
Nguyen T; Brownell GL; Holden SA; Kahl S; Miura M; Teicher BA
Radiat Res; 1993 Jan; 133(1):33-40. PubMed ID: 8434111
[TBL] [Abstract][Full Text] [Related]
11. Binding and distribution of Na2B12H11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy.
Otersen B; Haritz D; Grochulla F; Bergmann M; Sierralta W; Gabel D
J Neurooncol; 1997 May; 33(1-2):131-9. PubMed ID: 9151230
[TBL] [Abstract][Full Text] [Related]
12. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
13. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.
Chandra S; Kabalka GW; Lorey DR; Smith DR; Coderre JA
Clin Cancer Res; 2002 Aug; 8(8):2675-83. PubMed ID: 12171900
[TBL] [Abstract][Full Text] [Related]
14. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma.
Haselsberger K; Radner H; Pendl G
Cancer Res; 1994 Dec; 54(24):6318-20. PubMed ID: 7987820
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of sodium borocaptate (BSH) uptake by tumor cells induced by glutathione depletion and its radiobiological effect.
Yoshida F; Matsumura A; Yamamoto T; Kumada H; Nakai K
Cancer Lett; 2004 Nov; 215(1):61-7. PubMed ID: 15374633
[TBL] [Abstract][Full Text] [Related]
17. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
18. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
19. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T
Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510
[TBL] [Abstract][Full Text] [Related]
20. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
